Further reading

Alexander, S., Mead, A., and Peters, J. (eds.). (1998) TiPS receptor and ion channel nomenclature supplement, 9th edn.. Trends in Pharmacological Sciences, 19(3) (Suppl. 1).

Chalmers, D. T., and Behan, D. P. (2002) The use of constitutively active GPCRs in drug discovery and functional genomics. Nature Reviews Drug Discovery, 1, 599-608 [DOI: 10.1038/nrd872] [PubMed: 12402500].

Christopoulis, A. (2002) Allosteric binding sites on cell surface receptors: novel targets for drug discovery. Nature Reviews Drug Discovery, 1, 198-210 [DOI: 10.1038/nrd746].

Kreek, M. J., LaForge, K. S., and Butelman, E. (2002) Pharmacotherapy of addictions. Nature Reviews Drug Discovery, 1, 710-725 [DOI: 10.1038/nrd897] [PubMed: 12209151].

Maehle, A-H., Prull, C-R., and Halliwell, R. F. (2002) The emergence of the drug receptor theory. Nature Reviews Drug Discovery, 1, 637-641 [DOI: 10.1038/nrd875] [PubMed: 12402503].

Pouletty, P. (2002) Drug addictions: towards socially accepted and medically treatable diseases. Nature Reviews Drug Discovery, 1, 731-736 [DOI: 10.1038/nrd896] [PubMed: 12209153].

Schlyer, S., and Horuk, R. (2006) I want a new drug: G protein-coupled receptors in drug development. Drug Discovery Today, 11, 481-493 [DOI: 10.1016/j.drudis.2006.04.008].

Zhan-Guo, G., and Jacobson, K. A. (2006) Allosterism in membrane receptors. Drug Discovery Today, 11, 191-202 [DOI: 10.1016/S1359-6446(05)03689-5].